Cardiovascular diseases (CVD) due to hyperglycemia are a leading cause of mortality (Mulnier et al. 2006). This poses a significant health burden as the global prevalence of diabetes is surging (Mbanya et al. 2010). There is a growing interest to better understand the association between hyperglycemia and CVD, for example, acute myocardial infarction (AMI) (Soedamah-Muthu et al.

2006; Gardner 2014; Martın-timon et al. 2014). There is a robust link between chronic hyperglycemia and macrovascular complications (Marcovecchio et al. 2011), with AMI a major factor leading to higher deaths within the diabetic context (Kannel et al. 1974; Diabetes Control and Complications Trial Research Group, 1993; United Kingdom Prospective Diabetes Study, 1998). Damaging effects also occur in the acute setting, with stress-induced hyperglycemia linked to in-hospital deaths, cardiogenic shock,